Bausch Health Companies (BHC) vs Harrow (HROW)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Bausch Health Companies (BHC) has outperformed Harrow (HROW) over the past year, losing 3.8% versus a loss of 26.9%. Over five years, HROW leads with a +209.6% price change compared with -78.4% for BHC. Bausch Health Companies is the larger company by market cap ($2.26 billion vs $1.14 billion), about 2.0 times the size.
On valuation, Bausch Health Companies trades at a lower forward P/E (1.4x vs 11.0x for Harrow).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BHC | HROW |
|---|---|---|
| Share price | $6.04 | $30.52 |
| Market cap | $2.26B | $1.14B |
| 1-day change | -1.79% | -0.33% |
| YTD return | -11.51% | -37.51% |
| 1-year return | -3.76% | -26.92% |
| 5-year return | -78.41% | +209.61% |
| Forward P/E | 1.44 | 11.01 |
| EPS (TTM) | $-2.95 | $-0.99 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $8.00 | $54.85 |
| 52-week low | $4.33 | $28.54 |
| Distance from 52-week high | -24.50% | -44.36% |
| Analyst consensus | hold | strong_buy |
| Avg. price target upside | +24.17% | +112.98% |
| Average volume | 3.24M | 555.14K |
| Shares outstanding | 373.99M | 37.49M |
| Employees | 20,300 | 373 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- BHC has outperformed HROW by 23.2 percentage points over the past year.
About Bausch Health Companies
BHC stock →Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company.
Health Care · Biotechnology: Pharmaceutical Preparations · 20,300 employees
About Harrow
HROW stock →Harrow, Inc., an eyecare pharmaceutical company, engages in the discovery, development, and commercialization of ophthalmic pharmaceutical products in the United States. It operates through Branded and ImprimisRx segments.
Health Care · Biotechnology: Pharmaceutical Preparations · 373 employees
BHC vs HROW FAQ
Which is bigger, Bausch Health Companies or Harrow?
Bausch Health Companies (BHC) is larger, with a market capitalization of $2.26B compared with $1.14B for Harrow (HROW).
Which stock has performed better over the past year, BHC or HROW?
BHC returned -3.76% over the past 12 months, compared with -26.92% for HROW (price return, excluding dividends). Past performance does not predict future results.
Are Bausch Health Companies and Harrow in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.